50 results
8-K
EX-99.1
ACET
Adicet Bio Inc
14 May 24
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
4:03pm
, business operations, employee hiring and retention, and
ability to raise additional capital; Adicet’s ability to execute on its strategy including
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
depending on our hiring needs and fluctuations in our stock price, among other things. Approval of this Proposal No. 2 is contingent on the approval
8-K
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
studies, business operations, employee hiring and retention, and ability to raise additional capital; Adicet's ability to execute on its strategy
8-K
EX-99.1
d8srgspoyrozs vcaj2
22 Apr 24
Regulation FD Disclosure
4:31pm
PRE 14A
6j0i cg9rpiw5e
12 Apr 24
Preliminary proxy
5:23pm
8-K
EX-99.1
kr27se6bww958q
19 Mar 24
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
4:13pm
8-K
EX-99.1
l7fhxtg6q 3k2risvb4x
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
7pi g6kif2
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
EX-99.1
s8cs3avpu45hfnm
8 Nov 23
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
sbldje
9 Aug 23
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:17pm
8-K
EX-99.1
d06ojq9lrpb2
18 May 23
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
6:02am
8-K
EX-99.1
qyi9g0a znbv
9 May 23
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
4:14pm